PDF file: 441-1545_Pregnancy_and_Lactation.pdf
OPQ ID: 441-1545
Session: 441
Question number: Q-1545
Sessional paper: Q-1545
Title: Pregnancy and Lactation
Short description: 
Topic: vaccines
Identified concern: 
Keywords: 
Agencies: HC, PHAC, NACI
Date asked: 2023-05-25
Date tabled: 
Submitted by: Mr. Falk (Provencher)
Reply by: Minister of Health
Responded by: the Honourable Mark Holland
Pages: 7
Status: not processed
Alert: yellow
Questions asked: 7
Questions answered: 6
Percent responded: 86%
Referenced sources: Canada.ca
Referenced links: https://clinical-information.canada.ca/search/ci-rc.The, https://www.canada.ca/en/public-health/services/immunization/national-advisory-committeeon-immunization-naci/guidance-covid-19-vaccines-individuals-pregnant-breastfeeding.html, https://www.canada.ca/en/public-health/services/immunization/nationaladvisory-committee-on-immunization-naci/guidance-covid-19-vaccines-individuals-pregnantbreastfeeding.html#a10.NACI, https://www.canada.ca/en/publichealth/services/immunization/national-advisory-committee-on-immunization-naci/guidance-covid-19vaccines-individuals-pregnant-breastfeeding.html#a10NACI, https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunizationguide-part-4-active-vaccines/page-26-covid-19-vaccine.html
Official link: https://www.google.com/search?q=Q-1545+ourcommons.ca
PDF URL: https://ivim.ca/foi/opq/r/441-1545_Pregnancy_and_Lactation.pdf
TXT URL: https://ivim.ca/foi/opq/r/441-1545.txt
Original filename: Q-1545, Pregnancy and Lactation.pdf
Local source path: C:\Users\Dmitry\Documents\CODES\OPQ-App\data-raw\OPQ\ALL OPQ TO DATE\2022\Q-1545, Pregnancy and Lactation.pdf
Machine extracted at: 2026-06-30 12:58:25

References / links:
- https://clinical-information.canada.ca/search/ci-rc.The
- https://www.canada.ca/en/public-health/services/immunization/national-advisory-committeeon-immunization-naci/guidance-covid-19-vaccines-individuals-pregnant-breastfeeding.html
- https://www.canada.ca/en/public-health/services/immunization/nationaladvisory-committee-on-immunization-naci/guidance-covid-19-vaccines-individuals-pregnantbreastfeeding.html#a10.NACI
- https://www.canada.ca/en/publichealth/services/immunization/national-advisory-committee-on-immunization-naci/guidance-covid-19vaccines-individuals-pregnant-breastfeeding.html#a10NACI
- https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunizationguide-part-4-active-vaccines/page-26-covid-19-vaccine.html(d
- Canada.ca

Machine notes:
(none)

Question text preview:
With regard to COVID-19 vaccine safety and the messaging on the government's webpage titled "Vaccination and pregnancy: COVID-19":
(a) what is the scientific basis for government officials' statements that COVID-19 vaccines are categorically safe for pregnant and breastfeeding women;
(b) did Health Canada (HC), the Public Health Agency of Canada (PHAC), or the National Advisory Committee on
Immunization (NACI) identify a need for observational studies regarding potential vaccine-related health outcomes in breastfed infants and toddlers as a result of exposure to vaccinated mothers or their breastmilk to detect safety signals of concern, and implement necessary precautions, and, if so, what are the details of all such studies, including those that the government relied on, including, for each (i) who conducted the study, (ii) the methodology, (iii) the findings;
(c) if the answer to (b) is none, why were no such studies required;
(d) did HC,
PHAC, or NACI study or review studies on the impact of the vaccines on menstrual cycles, and, if so, what conclusions or estimates were reached in relation to the number and percentage of recipients whose cycles were impacted;
(e) what is HC's response to the peer-reviewed article by Thorp & Associates, titled "COVID-19 Vaccines: The Impact on Pregnancy Outcomes and Menstrual Function", and what changes, if any, were made to public vaccine guidance or advice as a result of the study's findings; and (f) does the government acknowledge that for certain individuals or age ranges, such as newborns, the risks associated with the vaccine outweigh the potential benefits and, if so, for which individuals does the government recognize that this situation may apply?